Mona Al Mukaddam, MD, MS
Endocrinology, Diabetes
Headshot of Mona Al Mukaddam, MD, MS

Mona Al Mukaddam, MD, MS

Endocrinology, Diabetes
Sees patients age 18 and up
Penn Endocrinology and Diabetes University City
Headshot of Mona Al Mukaddam, MD, MS
Penn Medicine Provider

About me

  • Director, Penn Bone Center
  • Professor of Clinical Medicine (Endocrinology, Diabetes and Metabolism)
  • Professor of Orthopaedic Surgery

My education and training

  • Lebanese UniversityMedical School
  • American University of Beirut Medical CenterResidency
  • University of Iowa Hospitals and ClinicsResidency
  • University of Pennsylvania Health SystemFellowship

Spoken languages

English
English
العربية
Arabic

Reviews

Average Rating

519 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
September 2026
Dr. Al Mukaddam is thorough, attentive (she listens to what you say), and very knowledgeable (she explains things clearly and with cited research). Plus, she's kind and encouraging.
Anonymous
September 2026
they took their time with me and as i ask them question they right on time in answering them
Anonymous
September 2026
She is a great doctor, any patient will feel lucky under her care.
Anonymous
July 2026
easy to talk to and gave clear, understandable explanations

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Al Mukaddam is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Mona Al Mukaddam, Robert Pignolo, Edward Hsiao, Kelly Wentworth, Jad Sfeir, Staci Kallish, Deborah Wenkert, Fredrick Kaplan Baseline Characteristics in Part 1 of the ongoing ANDECAL Study (ASH-FOP-201), a two-part Phase 2/3 Study of andecaliximab (anti-matrix metalloproteinase-9 mAb) in FOP , Oral presentation and poster at the FOP Drug Development Forum, Toronto: 2026


Robert J Pignolo MD, Caifeng Li, MD, PhD, Javier Bachiller-Corral, MD, Amanda McBride, MD, Sue Moran, MSN, Qian Li, PhD, Frederick S Kaplan, MD, Mona Al Mukaddam, MD, MS Zilurgisertib in Patients with Fibrodysplasia Ossificans Progressiva: Interim Results from the PROGRESS Study , Rapid Fire Oral Presentation and poster, Endocrine Society Annual Meeting: 2026


Rahaf Sultan, Valerie Bai, Mona Al Mukaddam Approach to Hypercalcemia in a Patient Taking Immune Checkpoint Inhibitor Therapy for Breast Cancer , Endocrine Society Annual Meeting, Chicago, IL: 2026


Cassandra Crompton, Kassidy Baum, Michael Silvey, Mona Al Mukaddam Comparison of Forteo® and PF708 teriparatide on improvements in bone mineral density , JAPhA Pharmacotherapy: 2026


Pignolo, Robert; Hsiao, Edward; Al Mukaddam, Mona; Baujat, Genevieve; Berglund, Staffan; Cheung, Angela; De Cunto, Carmen; Delai, Patricia; Haga, Nobuhiko ; Kannu, Peter; Mancilla, Edna; Marino, Rose; Shih, Fei; Strahs, Andrew; Kaplan, Frederick Palovarotene Impact on Fibrodysplasia Ossificans Progressiva (FOP): Data from Month 48 of the Phase 3 MOVE Trial , JBMR plus: 2026


Robert J. Pignolo, Edward C. Hsiao, Mona Al Mukaddam, Monica Brova, Daniella Olonilua, Alan L. Shields, Timothy P. LaBranche, Cori Ann Sherwin, Elaine A. Boing, Negar Karimian, Oyinkan Solanke, Frederick S. Kaplan Development of the Fibrodysplasia Ossificans Progressiva FLare EXperience Revised (FOP-FLEX-R©) Questionnaire: A patient-reported outcome measure , Bone: 2026


Alsayed Hasan M, Al Mukaddam M. Burosumab use in fibroblast growth factor-23-mediated hypophosphatemia in McCune-Albright syndrome/fibrous dysplasia. , JCEM Case Report: 2026


Scott C, Al Mukaddam M, Davis M, De Cunto CL, Hsiao EC, Pignolo RJ, Schwegler O, Artyomenko A, Croskery K, Hanman K, Sanchot B, Warnants E, Kaplan FS Identifying global trends from case reports of fibrodysplasia ossificans progressiva: a scoping review. , Ther Adv Musculoskelet Dis.: 2025


Rahaf Sultan and Mona Al Mukaddam "Bone Health and Prevalence of Low Bone Density/Osteoporosis in Gender Diverse Adults; A retrospective Study" , ASBMR annual meeting: 2025


Frederick S Kaplan, Mona Al Mukaddam, Genevieve Baujat, Alberto Hidalgo Bravo, Matthew Brown, Amanda Cali, Tae-Joon Cho, Corrie Crowe, Carmen L De Cunto, Patricia L R Delai, Robert J Diecidue, Elisabeth Marelise W Eekhoff, Lisa Friedlander, Clive S Friedman, Zvi Grunwald, Nobuhiko Haga, Edward C Hsiao, Richard Keen, Joseph A Kitterman, Charles Levy, Vrisha Madhuri, Rolf Morhart, J Coen Netelenbos, Christiaan Scott, Eileen M Shore, Michael Zasloff, Keqin Zhang, Robert J Pignolo Medical Guidelines for Fibrodysplasia Ossificans Progressiva. , JBMR Plus: 2025